BrainCo, a leading Chinese brain-computer-interface company, has closed a 700 million yuan Series B round led by multiple industrial-capital investors, an October 29 AI-daily roundup reported.
The proceeds will fund the registered clinical trials, mass-production factory construction and brain-computer-interface-and-AI fusion exploration for its fully implantable, fully wireless, fully functional BCI system.
The financing arrives as China's brain-computer-interface sector accelerates, following the country's approval of the world's first AI brain-computer-interface medical-device standard earlier this year and growing state backing for neural-interface research.
Analysts view large BCI rounds as a signal that the field is moving from laboratory demonstration toward regulated clinical and consumer deployment, with interface stability and biocompatibility as the gating challenges.
Source: AI-daily roundup / BrainCo (paraphrased and translated from Chinese technology-media reporting; reprinted for informational purposes with attribution).
